New immune drug tested for Tough-to-Treat colon cancer
NCT ID NCT06824064
Summary
This study is testing whether an experimental drug called RBS2418, which aims to boost the immune system's ability to fight cancer, can help control advanced colorectal cancer. It will involve about 150 adults whose cancer has continued to progress despite trying all standard treatments. Participants will receive either RBS2418 or a placebo, along with best supportive care, to see if the drug can slow cancer growth and extend life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Community Clinical Trials
RECRUITINGKingwood, Texas, 77339, United States
-
Tam Anh TP. Ho Chi Minh General Hospital
RECRUITINGHo Chi Minh City, Ho Chi Minh City, 70000, Vietnam
-
Tam Anh, Ha Noi General Hospital
RECRUITINGHà Nội, 10000, Vietnam
Conditions
Explore the condition pages connected to this study.